Cigna Corp. (CI) Tops Q4 EPS by 25c, Beats on Revenue; Offers FY24 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
CIGNA (CI) PT Raised to $360 at Goldman Sachs
February 5, 2024 7:22 AM ESTGoldman Sachs analyst Nathan Rich raised the price target on CIGNA (NYSE: CI) to $360.00 (from $352.00) while maintaining a Neutral rating.
The analyst comments "CI outperformed (+5.4% on 2/2 vs S&P +1.1%) after reporting 4Q23 EPS 3%/4% above GS/consensus (FactSet), raising its 2024 EPS guidance by ~1% to >$28.25 from >$28.00, and reemphasizing its prioritization of share repurchases as... More
